1. Cheng YW, Fischer M. Fecal microbiota transplantation. Clin Colon Rectal Surg. 2023; 36(2): 151-156. https://doi.org/10.1055/s-0043-1760865
2.
Zecheng L, Donghai L, Runchuan G, Yuan Q, Qi J, Yijia Z, et al. Fecal microbiota transplantation in obesity metabolism: a meta analysis and systematic review. Diabetes Res Clin Pract. 2023; 202: 110803.https://doi.org/10.1016/j.diabres.2023.110803
3.
Yu EW, Gao L, Stastka P, Cheney MC, Mahabamunuge J, Torres Soto M, et al. Fecal microbiota transplantation for the improvement of metabolism in obesity: the FMT-TRIM double-blind placebo-controlled pilot trial. PLoS Med. 2020; 17(3): e1003051. https://doi.org/10.1371/journal.pmed.1003051
4.
Zikou E, Koliaki C, Makrilakis K. The role of fecal microbiota transplantation (FMT) in the management of metabolic diseases in humans: a narrative review. Biomedicines. 2024; 12(8): 1871. https://doi.org/10.3390/biomedicines12081871
5.
Karimi M, Shirsalimi N, Hashempour Z, Omran HS, Sedighi E, Beigi F. Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Front Immunol. 2024; 15: 1439176. https://doi.org/10.3389/fimmu.2024.1439176
6.
Zhou X, Zhang X, Yu J. Gut mycobiome in metabolic diseases: mechanisms and clinical implication. Biomed J. 2024; 47(3): 100625. https://doi.org/10.1016/j.bj.2023.100625
7.
Horvath A, Zukauskaite K, Hazia O, Balazs I, Stadlbauer V. Human gut microbiome: therapeutic opportunities for metabolic syndrome-hype or hope?. Endocrinol Diabetes Metab. 2024; 7(1): e436. https://doi.org/10.1002/edm2.436
8.
Yuan L, Li Y, Chen M, Xue L, Wang J, Ding Y, et al. Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives. Appl Microbiol Biotechnol. 2024; 108(1): 156. https://doi.org/10.1007/s00253-024-13007-7
9.
Leong KSW, Jayasinghe TN, Wilson BC, Derraik JGB, Albert BB, Chiavaroli V, et al. Effects of fecal microbiome transfer in adolescents with obesity: the gut bugs randomized controlled trial. JAMA Netw Open. 2020; 3(12): e2030415. https://doi.org/10.1001/jamanetworkopen.2020.30415
10.
Allegretti JR, Kassam Z, Mullish BH, Chiang A, Carrellas M, Hurtado J, et al. Effects of fecal microbiota transplantation with oral capsules in obese patients. Clin Gastroenterol Hepatol. 2020; 18(4): 855-863. https://doi.org/:10.1016/j.cgh.2019.07.006
11.
Xue L, Deng Z, Luo W, He X, Chen Y. Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial. Front Cell Infect Microbiol. 2022; 12: 759306. https://doi.org/10.3389/fcimb.2022.759306
12.
Mocanu V, Zhang Z, Deehan EC, Kao DH, Hotte N, Karmali S, et al. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nat Med. 2021; 27(7): 1272-1279. https://doi.org/10.1038/s41591-021-01399-2
13.
Lahtinen P, Juuti A, Luostarinen M, Niskanen L, Liukkonen T, Tillonen J, et al. Effectiveness of fecal microbiota transplantation for weight loss in patients with obesity undergoing bariatric surgery: a randomized clinical trial. JAMA Netw Open. 2022; 5(12): e2247226. https://doi.org/10.1001/jamanetworkopen.2022.47226
14.
Ng SC, Xu Z, Mak JWY, Yang K, Liu Q, Zuo T, et al. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. Gut. 2022; 71(4): 716-723. https://doi.org/10.1136/gutjnl-2020-323617
15.
Su L, Hong Z, Zhou T, Jian Y, Xu M, Zhang X, et al. Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation. Sci Rep. 2022; 12(1): 1152. https://doi.org/10.1038/s41598-022-05127-9
16.
Wu Z, Zhang B, Chen F, Xia R, Zhu D, Chen B, al. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: a randomized, controlled, prospective study. Front Cell Infect Microbiol. 2023; 12: 1089991. https://doi.org/10.3389/fcimb.2022.1089991
17.
Xu TC, Liu Y, Yu Z, Xu B. Gut-targeted therapies for type 2 diabetes mellitus: a review. World J Clin Cases. 2024; 12(1): 1-8. https://doi.org/10.12998/wjcc.v12.i1.1
18.
Ghorbani Y, Schwenger KJP, Sharma D, Jung H, Yadav J, Xu W, et al. Effect of faecal microbial transplant via colonoscopy in patients with severe obesity and insulin resistance: a randomized double-blind, placebo-controlled Phase 2 trial. Diabetes Obes Metab. 2023; 25(2): 479-490. https://doi.org/10.1111/dom.14891
19.
Zhu M, Dagah OMA, Silaa BB, Lu J. Thioredoxin/Glutaredoxin systems and gut microbiota in nafld: interplay, mechanism, and therapeutical potential. Antioxidants (Basel). 2023; 12(9): 1680. https://doi.org/10.3390/antiox12091680
20.
Riveros NFH, García-Corredor L, Martínez-Solarte MA, González-Clavijo A. Effect of bifidobacterium intake on body weight and body fat in overweight and obese adult subjects: a systematic review and meta-analysis. J Am Nutr Assoc. 2024; 43(6): 519-531. https://doi.org/10.1080/27697061.2024.2320192
21.
Li CP, Chen CC, Hsiao Y, Kao CH, Chen CC, Yang HJ, et al. The role of lactobacillus plantarum in reducing obesity and inflammation: a meta-analysis. Int. J. Mol. Sci. 2024; 25(14): 7608. https://doi.org/10.3390/ijms25147608
22.
Qiu B, Liang JX, Li C. Effects of fecal microbiota transplantation in metabolic syndrome: a meta-analysis of randomized controlled trials. PLoS One. 2023; 18(7): e0288718. https://doi.org/10.1371/journal.pone.0288718
23.
Hemachandra S, Rathnayake SN, Jayamaha AA, Francis BS, Welmillage D, Kaur DN, et al. Fecal microbiota transplantation as an alternative method in the treatment of obesity. Cureus. 2025; 17(1): e76858. https://doi.org/10.7759/cureus.76858
24.
Puljiz Z, Kumric M, Vrdoljak J, Martinovic D, Ticinovic Kurir T, Ozren Krnic M, et al. Obesity, gut microbiota, and metabolome: from pathophysiology to nutritional interventions. Nutrients. 2023; 15(10): 2236. https://doi.org/10.3390/nu15102236
25.
Yarahmadi A, Afkhami H, Javadi A, Kashfi M. Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review. Diabetol Metab Syndr. 2024; 16(1): 308. https://doi.org/10.1186/s13098-024-01561-z
26.
Mansour S, Alkhaaldi SMI, Sammanasunathan AF, Ibrahim S, Farhat J, Al-Omari B. Precision nutrition unveiled: gene-nutrient interactions, microbiota dynamics, and lifestyle factors in obesity management. Nutrients. 2024; 16(5): 581. https://doi.org/10.3390/nu16050581
27.
Zhang L, Wang P, Huang J, Xing Y, Wong FS, Suo J, et al. Gut microbiota and therapy for obesity and type 2 diabetes. Front Endocrinol (Lausanne). 2024; 15: 1333778. https://doi.org/10.3389/fendo.2024.1333778
28.
Perler BK, Friedman ES, Wu GD. The role of the gut microbiota in the relationship between diet and human health. Annu Rev Physiol. 2023; 85: 449-468. https://doi.org/10.1146/annurev-physiol-031522-092054
29.
Luqman A, Hassan A, Ullah M, Naseem S, Ullah M, Zhang L, et al. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder. Front Immunol. 2024; 15: 1321395. https://doi.org/10.3389/fimmu.2024.1321395
30.
Gómez-Pérez AM, Muñoz-Garach A, Lasserrot-Cuadrado A, Moreno-Indias I, Tinahones FJ. Microbiota Transplantation in individuals with type 2 diabetes and a high degree of insulin resistance. Nutrients. 2024; 16(20): 3491. https://doi.org/10.3390/nu16203491
31.
Tavassol ZH, Ejtahed HS, Atlasi R, Saghafian F, Khalagi K, Hasani-Ranjbar S, et al. Alteration in gut microbiota composition of older adults is associated with obesity and its indices: a systematic review. J Nutr Health Aging. 2023; 27(10): 817-823. https://doi.org/10.1007/s12603-023-1988-8
32.
Crudele L, Gadaleta RM, Cariello M, Moschetta A. Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. eBioMedicine. 2023; 97: 104821. https://doi.org/10.1016/j.ebiom.2023.104821
33.
Colangeli L, Marcillo DIE, Simonelli V, Iorio E, Rinaldi T, Sbraccia P, et al. The crosstalk between gut microbiota and white adipose tissue mitochondria in obesity. Nutrients. 2023; 15(7): 1723. https://doi.org/10.3390/nu15071723
34.
Li X, Huang J, Yun J, Zhang G, Zhang Y, Zhao M, et al. d-Arabitol ameliorates obesity and metabolic disorders via the gut microbiota-SCFAs-WAT browning axis. J. Agric. Food Chem. 2023; 71: 522-534. https://doi.org/10.1021/acs.jafc.2c06674
35.
Sochacka K, Kotowska A, Lachowicz-Wiśniewska S. The role of gut microbiota, nutrition, and physical activity in depression and obesity—interdependent mechanisms/co-occurrence. Nutrients. 2024; 16(7): 1039.https://doi.org/10.3390/nu16071039
36.
Pillai SS, Gagnon CA, Foster C, Ashraf AP. Exploring the gut microbiota: key insights into its role in obesity, metabolic syndrome, and type 2 diabetes. J Clin Endocrinol Metab. 2024; 109(11): 2709-2719. https://doi.org/10.1210/clinem/dgae499
37.
Huang Y, Cao J, Zhu M, Wang Z, Jin Z, Xiong Z. Bacteroides fragilis aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota. Microbiol Spectr. 2024; 12(4): e0339323. https://doi.org/10.1128/spectrum.03393-23
38.
Zhang XL, Chen L, Yang J, Zhao SS, Jin S, Ao N, et al. Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism. Front Microbiol. 2023; 14: 1117644. https://doi.org/10.3389/fmicb.2023.1117644
39.
Micic D, Polovina S, Micic D, Macut D. OBESITY AND GUT-BRAIN AXIS. Acta Endocrinol (Buchar). 2023 Apr-Jun;19(2):234-240. https://doi.org/10.4183/aeb.2023.234
40.
Barton JR, Londregan AK, Alexander TD, Entezari AA, Covarrubias M, Waldman SA. Enteroendocrine cell regulation of the gut-brain axis. Front Neurosci. 2023; 17: 1272955. https://doi.org/10.3389/fnins.2023.1272955
Copyright: © 2025 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
